Marksans Pharma Limited
Share Price Target & Analysis

NSE:MARKSANS

298.95

VWAP

297.6

Open

296.65

Close

303.1

High

294.8

Low

350.95

52 Week High

300.10 ⇧
3.45 (1.16%)

MARKSANS

(PHARMA)
74% Momentum

Sideways to Positive

155

52 Week Low

7.4

EPS

42.27

PE

7.9

PB

Economical
Quality

Gold
Valuation

#Analysis

NSE: MARKSANS Share Price Financial Analysis & Valuation

Marksans Pharma Limited (MARKSANS) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Small Cap company with Market Capitalization of Rs 2308.5 (in Cr). Total number of free float shares are 40.9 (in Lacs). Marksans Pharma Limited is listed on NSE with Exchange ID - INE750C01026 and trading code is NSE:MARKSANS with short name Marksans Pharma.

In the past 1 year, Marksans Pharma Limited has declared an equity dividend of Rs 0.3 per share. At the current share price of MARKSANS at Rs 300.10, this results in a dividend yield of 0.1 %.

As per the Fundamental Analysis of NSE:MARKSANS, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine MARKSANS underlying value and future prospects. All of this data is available in MARKSANS financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:MARKSANS, it is clearly understood that MARKSANS is Economical performer in terms of earnings and profit margins with an EPS of 7.4. NSE:MARKSANS book value per share as of today is 37.99. The current price to book ratio for MARKSANS as of Oct 28, 2026 is 7.9.

Valuation of the Stock: The current valuation of MARKSANS stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of MARKSANS whether to BUY this stock at current valuation. The delivery percentage of MARKSANS is 501643% is very crucial parameter which shows that 501643% investors are anticipating that the price of MARKSANS share should go up with VWAP at 298.95.

Now, the main question is whether to BUY or SELL, NSE:MARKSANS at current valuation.
As per latest Analysis No. #3020:-

⇑ STRONG BUY MARKSANS if All Greens

⇗ BUY MARKSANS (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD MARKSANS (With Stop Loss) if only 1 Green

⇘ SELL MARKSANS if NO Green Indicator

NSE: MARKSANS Share Price Today (Oct 28, 2026)

(Marksans Pharma Limited Daily Analysis on the basis of MARKSANS Intraday Graph & Trend)

Marksans Pharma Limited share price moved Up by 1.16% from its previous close of Rs 296.65. MARKSANS stock last traded price is 300.10. MARKSANS share price trend is Up with a total of 1026420 stocks traded till now. It has touched an intraday high of Rs 303.1 and an intraday low of Rs 294.8. The MARKSANS trading at 300.10, Up by Rs. 3.45, or 1.16 percent which suggests that most of the Traders are anticipating that the price of MARKSANS share should go Up.

NSE: MARKSANS Share Price Tomorrow Prediction

(Marksans Pharma Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of MARKSANS)

Marksans Pharma Limited share price moved Up by 1.16%. MARKSANS share price short term trend is Up. It suggests that MARKSANS Share Price for Tomorrow remains the same with VWAP at 298.95 will be treated as stop loss for intraday traders. Marksans Pharma Limited Long term investors can follow the MARKSANS long term trend as mentiond in future forecast table.

NSE Code

NSE: MARKSANS

MARKSANS Share Price Today

 300.10

MARKSANS Share Price Target Prediction for 2026 ^

 243.5 - 352.7

MARKSANS Share Price Target Prediction for 2027*^

 352.7 - 375.7

MARKSANS Share Price Target Prediction for 2028*^

 375.7 - 402

MARKSANS Share Price Target Prediction for 2029*^

 422

MARKSANS Share Price Target Prediction for 2030*^

 434

MARKSANS Share Price Target Prediction for 2035*^

 473
MARKSANS Current Book Value
37.8

*Marksans Pharma Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^MARKSANS share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

MARKSANS Technical Analysis

Candlestick Pattern: @330.15

MARKSANS Moving Averages

BUY (12) NEUTRAL (0) SELL (2)
MA Simple Action S1 Expo Action E2
MA_5 332.01 SELL 331.52 SELL
MA_12 328.14 BUY 326.79 BUY
MA_20 326.47 BUY 320.53 BUY
MA_32 302.35 BUY 308.02 BUY
MA_50 290.37 BUY 295.55 BUY
MA_100 266.62 BUY 271.83 BUY
MA_200 217.45 BUY 240.84 BUY

MARKSANS Trend Oscillators

BUY (3) NEUTRAL (0) SELL (1)
Trend Oscillators Value Action
Bollinger Bands 326.47 Uptrend
MACD -1.42 SELL
ADX 40.41 Strong Trend
DMI (+/-) 28.23 / 12.74 Uptrend

MARKSANS Momentum Oscillators

BUY (4) NEUTRAL (7) SELL (1)
Momentum Oscillators Value Action
RSI 60.7 Neutral
STOCHASTIC_K (Fast) 33.64 Neutral
STOCHASTIC_D (Slow) 54.74 Neutral
CCI 71.08 Neutral
PSAR 313.84 BUY
TRUE RANGE 11.35 BUY
ATR 13.35 BUY
WILLIAMS R -53.73 Neutral
TRIX 0 Neutral
STOCHASTIC RSI K 0 Oversold
STOCHASTIC RSI D 58.12 Neutral
MOMENTUM 51.2 BUY

MARKSANS Last 1 Year Trend

Duration Value
1 Year 92.42%
3 Months 30.62%
1 Month 18.35%
1 Week -0.71%

MARKSANS Technical Analysis Summary

Updated on 2026-09-09
Action Overall (%)
BUY 63%
NEUTRAL / HOLD 23%
SELL 13%

(powered by Zerodha)

Most popular Questions & Answers about MARKSANS

Marksans Pharma Limited Frequently Asked Questions (FAQs)

Marksans Pharma Limited stock last traded price is 300.10. MARKSANS share price moved Up by 1.16% from its previous close of Rs 296.65.

Marksans Pharma Limited share price trend is Up with a total of 1026420 stocks traded till now. It has touched an intraday high of Rs 354.4595 and an intraday low of Rs 294.8. The MARKSANS trading at 300.10, Up by Rs. 3.45, or 1.16 percent which suggests that most of the Traders are anticipating that the price of MARKSANS share should go Up and the Stop Loss will be around 298.95.

The market cap of Marksans Pharma Limited is ₹2308.5 (in Cr) as of Oct 27, 2026.

The current price to earning ratio for Marksans Pharma Limited as of Oct 27, 2026 is 42.27.

The current price to book ratio for Marksans Pharma Limited as of Oct 27, 2026 is 7.9.

The highest price of Marksans Pharma Limited stock is ₹350.95 in the last 52-week.

The lowest price of Marksans Pharma Limited stock is ₹155 in the last 52-week.

Marksans Pharma Limited share trading at ₹300.10, Up by Rs. 3.45, or 1.16 percent which suggests that most of the traders are anticipating that the price of MARKSANS share should go Up.

In 2026, Stock price target for Marksans Pharma Limited (MARKSANS) will be around ₹243.5 on downside and ₹352.7 on upside. Marksans Pharma Limited share price target is based on current financial year earings of the company.

In 2027, Stock price target for Marksans Pharma Limited (MARKSANS) will be around ₹352.7 on downside and ₹375.7 on upside. Marksans Pharma Limited share price target is based on forecasted future earnings of the company.

In 2028, Stock price target for Marksans Pharma Limited (MARKSANS) will be around ₹375.7 on downside and ₹402 on upside. Marksans Pharma Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Marksans Pharma Limited (MARKSANS) will be around ₹434 Marksans Pharma Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of MARKSANS.

The price of Marksans Pharma Limited (MARKSANS) shares moved by 1.16%. The short-term trend for MARKSANS share price is Up. It implies that the share price of MARKSANS will stay the same tomorrow and that intraday traders should treat VWAP at 298.95 as a stop loss. Investors with a long-term outlook can track MARKSANS long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of MARKSANS stock is 88.7. Compared to the current market price of 300.10 INR, the MARKSANS stock is Overvalued by 70.4%.

As per the fundamental analysis of Marksans Pharma Limited (MARKSANS), it is of Economical quality in terms of earnings and profit margins with an EPS of 7.4. Marksans Pharma Limited book value per share as of today is 37.99. The current price to book ratio for MARKSANS as of Oct 28, 2026 is 7.9.


NSE:MARKSANS News & Other Useful Information about MARKSANS Share Price


Peer Comparison of NSE: MARKSANS

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1751.20 16.35 97.89
DIVISLAB 9505.50 115.55 663.06
MEDICAMEQ 263.80 12.15 208.08
CIPLA 1350.00 51.67 434.02
DRREDDY 1310.00 53.19 380.63
TORNTPHARM 4625.00 87.32 235.7
BIOCON 332.45 1.27 166.51
LUPIN 1952.00 154.86 718.33
ALKEM 5078.00 212.33 1218.48
AUROPHARMA 1627.50 46.49 403.84
ABBOTINDIA 25515.00 766.11 2448.41
GLAXO 2472.40 63.65 147.25
IPCALAB 1980.80 56.72 329.23
LAURUSLABS 2142.00 20.74 102.57
LALPATHLAB 1901.80 39.68 157.23
PFIZER 3709.80 170.54 963.41
AJANTPHARM 3353.60 89.3 363.23
SANOFI 3075.00 158.05 332.96
NATCOPHARM 794.55 82.14 505
APLLTD 766.90 48.4 295.69
JBCHEPHARM 2408.90 54.16 251.48
GLENMARK 2265.70 1.24 881.78
AAREYDRUGS 106.58 2.39 53.38
JUBLPHARMA 959.80 4.35 145.63
SPARC 179.24 48.14 40.45
GRANULES 830.55 23.25 180.42
ASTRAZEN 6073.00 86.44 364.29
CAPLIPOINT 2352.40 55.52 285.6
FDC 353.80 21.19 161.21
HIKAL 201.83 9.34 96.63
Updated at: 2026-10-27 15:31:21

Feel free to contact us, in case of any queries.

Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 2490.00 -18.00 (-0.72%) | ADANIPORTS 1754.50 2.00 (0.11%) | APOLLOHOSP 7791.50 -52.50 (-0.67%) | ASIANPAINT 2277.00 -45.00 (-1.94%) | AXISBANK 1205.70 -14.30 (-1.17%) | BAJAJ-AUTO 10390.00 319.00 (3.17%) | BAJAJFINSV 1677.00 6.10 (0.37%) | BAJFINANCE 912.00 -6.70 (-0.73%) | BEL 367.95 4.95 (1.36%) | BHARTIARTL 1978.80 61.30 (3.2%) | CIPLA 1350.00 -5.00 (-0.37%) | COALINDIA 398.00 -7.00 (-1.73%) | DRREDDY 1310.00 -0.90 (-0.07%) | EICHERMOT 7165.00 65.50 (0.92%) | GRASIM 2900.80 -49.20 (-1.67%) | HCLTECH 1420.00 3.00 (0.21%) | HDFCBANK 680.20 -7.85 (-1.14%) | HDFCLIFE 513.60 -5.40 (-1.04%) | HINDALCO 891.20 5.55 (0.63%) | HINDUNILVR 1818.00 -0.60 (-0.03%) | ICICIBANK 1386.90 -16.10 (-1.15%) | INDIGO 4596.50 -11.50 (-0.25%) | INFY 1163.00 -3.00 (-0.26%) | ITC 260.00 -0.50 (-0.19%) | JIOFIN 207.24 2.01 (0.98%) | JSWSTEEL 1252.70 -7.30 (-0.58%) | KOTAKBANK 442.50 1.75 (0.4%) | LT 3665.10 -14.90 (-0.4%) | M&M 2858.40 5.30 (0.19%) | MARUTI 11450.00 230.00 (2.05%) | MAXHEALTH 845.00 10.00 (1.2%) | NESTLEIND 1180.50 7.00 (0.6%) | NTPC 301.80 1.80 (0.6%) | ONGC 229.85 1.41 (0.62%) | POWERGRID 251.75 4.75 (1.92%) | RELIANCE 1196.20 -5.60 (-0.47%) | SBILIFE 1633.00 -10.70 (-0.65%) | SBIN 945.10 -15.70 (-1.63%) | SUNPHARMA 1751.20 11.20 (0.64%) | TATACONSUM 1000.00 63.50 (6.78%) | TATASTEEL 171.42 1.48 (0.87%) | TCS 2496.90 -38.10 (-1.5%) | TECHM 1811.40 16.40 (0.91%) | TITAN 4365.90 42.90 (0.99%) | TMPV 261.20 -2.50 (-0.95%) | TRENT 2820.60 66.60 (2.42%) | ULTRACEMCO 11150.00 -30.00 (-0.27%) | WIPRO 187.00 -2.20 (-1.16%) |
Top